AstraZeneca PLC (AZN)

AstraZeneca Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 6, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	297,698	203,171	209,268	209,442	182,034	131,259
Market Cap Growth	40.81%	-2.91%	-0.08%	15.06%	38.68%	-0.69%
Enterprise Value	322,565	228,175	234,801	238,391	209,520	149,836
Last Close Price	193.03	127.23	130.76	132.48	112.67	98.23
PE Ratio	31.67	28.88	35.14	63.70	1625.31	41.07
PS Ratio	5.12	3.76	4.57	4.72	4.87	4.93
PB Ratio	6.48	4.97	5.34	5.65	4.63	8.39
P/FCF Ratio	23.52	20.45	23.29	24.03	37.36	34.20
P/OCF Ratio	19.66	17.13	20.23	21.35	30.53	27.35
EV/Sales Ratio	5.55	4.22	5.13	5.38	5.60	5.63
EV/EBITDA Ratio	15.80	12.99	16.51	17.35	31.27	21.44
EV/EBIT Ratio	20.28	17.65	24.34	27.05	72.32	34.29
EV/FCF Ratio	25.48	22.96	26.14	27.35	43.01	39.04
Debt / Equity Ratio	0.71	0.75	0.76	0.84	0.85	1.45
Debt / EBITDA Ratio	1.57	1.70	2.04	2.23	4.81	3.15
Debt / FCF Ratio	2.58	3.07	3.30	3.57	6.85	5.92
Asset Turnover	0.53	0.53	0.46	0.44	0.44	0.42
Inventory Turnover	1.59	1.80	1.59	1.26	1.85	1.45
Quick Ratio	0.69	0.67	0.58	0.62	0.67	0.67
Current Ratio	0.88	0.93	0.82	0.86	1.16	0.96
Return on Equity (ROE)	21.67%	17.59%	15.64%	8.63%	0.42%	20.80%
Return on Assets (ROA)	9.06%	7.88%	6.10%	5.46%	2.10%	4.26%
Return on Invested Capital (ROIC)	18.54%	16.27%	13.35%	13.75%	6.00%	11.87%
Return on Capital Employed (ROCE)	19.80%	17.00%	13.70%	12.60%	3.50%	9.40%
Earnings Yield	3.16%	3.46%	2.85%	1.57%	0.06%	2.44%
FCF Yield	4.25%	4.89%	4.29%	4.16%	2.68%	2.92%
Dividend Yield	1.62%	2.44%	2.22%	2.19%	2.55%	2.85%
Payout Ratio	52.00%	65.80%	75.25%	132.72%	3442.86%	111.77%
Buyback Yield / Dilution	0.08%	-0.06%	-0.13%	-9.32%	-8.68%	-0.92%
Total Shareholder Return	1.70%	2.37%	2.09%	-7.13%	-6.13%	1.93%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q